It's really time for travel bans for flights and cargo ships going to/coming from West Africa. This newly mutated Ebola is popping up in more countries, way faster than health workers can slow down.
Ebola virus in Guinea ‘most aggressive, near totally fatal’
- Thread starter 69 others
- Start date
It's really time for travel bans for flights and cargo ships going to/coming from West Africa. This newly mutated Ebola is popping up in more countries, way faster than health workers can slow down.
Mr. Somebody
Friend Of A Friend
Doctors struggle to treat Ebola patients
Obama: U.S. prepared for Ebola
"The importance of this for America needs to be understood," President Barack Obama said on Friday about the summit.
He added later that Africa "happens to be one of the continents where America is most popular and people feel a real affinity for our way of life."
Here are five reasons that the U.S.-Africa Leader's Summit, which kicked off on Monday, is important:
1. Health scare: The health problems in Africa were underscored this week when an Ebola outbreak prompted leaders of two nations to cancel their trips to Washington.
Liberian President Ellen Johnson Sirleaf, a Nobel Peace Prize winner, and Ernest Bai Koroma, the leader of Sierra Leone, both said they would remain in their countries.
Ebola has killed more than 700 people in three nations: Guinea, Liberia and Sierra.
Summit leaders, and even Obama, have stressed there is no risk to Washingtonians from those arriving from Africa this week.
Obama said anyone who might have been exposed to the virus would be screened both in their home countries and upon arrival in the United States.
But worry over the worsening outbreak only highlighted challenges Africa faces in combating disease and poverty, despite the billions in U.S. aid over the years.
"This is an uphill challenge for them," said Gayle Smith, Obama's senior director for development and Democracy, noting both Liberia and Sierra Leone had recently emerged from periods of civil war.
Obama hopes to move past the traditional elements of humanitarian aid to Africa, focusing instead on potential trade.
But promoting commercial ties with countries engulfed in Ebola outbreaks could prove to be difficult. The State Department warned against non-essential travel to Sierra Leone and Libera last week, and some schools and businesses have closed.
"The timing is very unfortunate, and no one would have wished for this," said Howard French, an associate professor of international affairs at Columbia University. "Having high-level discussions between the U.S. and Africa on business and investment are infrequent. So to the extent that this distracts from that I think will be regretted all around."
I think we know whats happening now.
Its so demonic, friends.
Mr. Somebody
Friend Of A Friend
Yes like a form of sanctions for progressing nations in Africa.
Its so demonic, friends.
NZA
LOL
some of you believe white people either are a race of super geniuses or have magical powers
You sound silly. We know cacs well enough to know that the ones with the resources to do so are very nefarious and smart. It's obvious they're running game on african with this ebola shyt. A damn ebola outbreak right before the conference starts stop it. I smell cacs all over this. This hurts a lot of what the summit was about. What prospecting business man is going to go to africa with ebola scares looming.
Who's going to step in to offer Africans a vaccine for the right price.........
Cacs obviously.
NZA
LOL
i dont doubt some want to do these things, i do doubt they can spread it across at least 3 countries
and poor west africans are not a great market for new drugs, breh
and as profits go, this is a disease that only comes and goes in spurts
We have bases in all countries effected and people able to spread it among the poor. I think you're being naive regarding the capabilities of white supremacists. The timing to me is not a coincidence so someone wants to keep certain investment out of africa but at the same time profit from the death of Africans. This is how cacs do things.
You didn't say anything here outside of you being a bytch who needs attention by any means.
Now bytch, please be quiet.
But I don't answer stupid questions.
THASTUNNA
All Star
when I was coming back from my Florida trip in June I seen a couple of UN trucks.. i was like wtf they doing here
Could it be that they're built in the South East U.S.?
@ Mowgli switching characters to shyt on CACs
http://www.telegraph.co.uk/news/wor...ea-street-for-hours-over-infection-fears.html
In Guinea this man was left lying in the street for nearly 5 hours because no one knew if he had ebola.
In Guinea this man was left lying in the street for nearly 5 hours because no one knew if he had ebola.
TommyHilltrigga
Here comes THE BOOM!
The United States of America, yesterday, dashed the hope of an early cure for Ebola Virus victims in Nigeria when it refused to share the trial drug with Nigeria. US President Barak Obama says it would be premature to share the experimental drug with Africa.
The Federal Government had earlier reached out to the United States Centre for Disease Control and Prevention, CDC, in Atlanta, to request for the drug for treatment of EVD affected persons in Nigeria, but President Obama turned down the request, saying it would be far more beneficial to focus on prevention instead.
Nigeria recorded its first Ebola Virus disease fatality on Tuesday when one of the nurses who was one of the primary contacts of the American-Liberian, Patrick Sawyer, passed on. The doctor who treated Sawyer, who died in the country after flying into Lagos, is now ill with Ebola and six other primary contacts are currently ill with the disease in a Lagos hospital where they are quarantined.
Minister of Health, Professor Onyebuchi Chukwu and Minister of Information, Mr. Labaran Maku had disclosed on Wednesday after the Federal Executive Council meeting in Abuja that the Federal Government was awaiting the response of the request it made to the CDC on Tuesday.
Addressing the 50 African leaders at the US-African Summit in Washington, President Obama stated that it is “premature” to send an experimental medicine for the treatment of Ebola to West Africa, as he lacked enough information to approve the drug that was already being used on two American aid workers whose conditions were said to have improved by varying degrees.
“We’ve got to let the science guide us and I don’t think all the information is in on whether this drug is helpful. The Ebola virus, both currently and in the past, is controllable if you have a strong public health infrastructure in place.
“The countries affected are the first to admit that what’s happened here is the public health systems have been overwhelmed. They weren’t able to identify and then isolate cases quickly enough.
“As a consequence, it spread more rapidly than has been typical with the periodic Ebola outbreaks that occurred previously,” he remarked.
Palliative
As a palliative, President Obama announced plans by the US to spend $110 million annually, for three to five years, totall ing $330-$550 million, to help African nations develop rapid reaction peacekeeping forces.
The Ebola virus causes viral hemorrhagic fever, which refers to a group of viruses that affect multiple organ systems in the body and are often accompanied by bleeding.
The experimental medicine is a three-mouse monoclonal antibody, meaning that mice were exposed to fragments of the Ebola virus and then the antibodies generated within the mice’s blood were harvested to create the medicine. It works by preventing the virus from entering and infecting new cells.
Developed by a San Diego Company, Mapp Biopharmaceutical, the experimental serum had never been tried before on human beings but had shown promise in small experiments with monkeys. Company documents show that four monkeys infected with Ebola survived after being given the therapy within 24 hours after infection.
In the monkeys, the experimental serum had been given within 48 hours of infection. Two of four other monkeys that started therapy within 48 hours after infection also survived. One monkey that was not treated died within five days of exposure to the virus.
Source:Nigeria recorded its first Ebola Virus disease fatality on Tuesday when one of the nurses who was one of the primary contacts of the American-Liberian, Patrick Sawyer, passed on. The doctor who treated Sawyer, who died in the country after flying into Lagos, is now ill with Ebola and six other primary contacts are currently ill with the disease in a Lagos hospital where they are quarantined.
Minister of Health, Professor Onyebuchi Chukwu and Minister of Information, Mr. Labaran Maku had disclosed on Wednesday after the Federal Executive Council meeting in Abuja that the Federal Government was awaiting the response of the request it made to the CDC on Tuesday.
Addressing the 50 African leaders at the US-African Summit in Washington, President Obama stated that it is “premature” to send an experimental medicine for the treatment of Ebola to West Africa, as he lacked enough information to approve the drug that was already being used on two American aid workers whose conditions were said to have improved by varying degrees.
“We’ve got to let the science guide us and I don’t think all the information is in on whether this drug is helpful. The Ebola virus, both currently and in the past, is controllable if you have a strong public health infrastructure in place.
“The countries affected are the first to admit that what’s happened here is the public health systems have been overwhelmed. They weren’t able to identify and then isolate cases quickly enough.
“As a consequence, it spread more rapidly than has been typical with the periodic Ebola outbreaks that occurred previously,” he remarked.
Palliative
As a palliative, President Obama announced plans by the US to spend $110 million annually, for three to five years, totall ing $330-$550 million, to help African nations develop rapid reaction peacekeeping forces.
The Ebola virus causes viral hemorrhagic fever, which refers to a group of viruses that affect multiple organ systems in the body and are often accompanied by bleeding.
The experimental medicine is a three-mouse monoclonal antibody, meaning that mice were exposed to fragments of the Ebola virus and then the antibodies generated within the mice’s blood were harvested to create the medicine. It works by preventing the virus from entering and infecting new cells.
Developed by a San Diego Company, Mapp Biopharmaceutical, the experimental serum had never been tried before on human beings but had shown promise in small experiments with monkeys. Company documents show that four monkeys infected with Ebola survived after being given the therapy within 24 hours after infection.
In the monkeys, the experimental serum had been given within 48 hours of infection. Two of four other monkeys that started therapy within 48 hours after infection also survived. One monkey that was not treated died within five days of exposure to the virus.
Source:vanguardngr.com
The Federal Government had earlier reached out to the United States Centre for Disease Control and Prevention, CDC, in Atlanta, to request for the drug for treatment of EVD affected persons in Nigeria, but President Obama turned down the request, saying it would be far more beneficial to focus on prevention instead.
Nigeria recorded its first Ebola Virus disease fatality on Tuesday when one of the nurses who was one of the primary contacts of the American-Liberian, Patrick Sawyer, passed on. The doctor who treated Sawyer, who died in the country after flying into Lagos, is now ill with Ebola and six other primary contacts are currently ill with the disease in a Lagos hospital where they are quarantined.
Minister of Health, Professor Onyebuchi Chukwu and Minister of Information, Mr. Labaran Maku had disclosed on Wednesday after the Federal Executive Council meeting in Abuja that the Federal Government was awaiting the response of the request it made to the CDC on Tuesday.
Addressing the 50 African leaders at the US-African Summit in Washington, President Obama stated that it is “premature” to send an experimental medicine for the treatment of Ebola to West Africa, as he lacked enough information to approve the drug that was already being used on two American aid workers whose conditions were said to have improved by varying degrees.
“We’ve got to let the science guide us and I don’t think all the information is in on whether this drug is helpful. The Ebola virus, both currently and in the past, is controllable if you have a strong public health infrastructure in place.
“The countries affected are the first to admit that what’s happened here is the public health systems have been overwhelmed. They weren’t able to identify and then isolate cases quickly enough.
“As a consequence, it spread more rapidly than has been typical with the periodic Ebola outbreaks that occurred previously,” he remarked.
Palliative
As a palliative, President Obama announced plans by the US to spend $110 million annually, for three to five years, totall ing $330-$550 million, to help African nations develop rapid reaction peacekeeping forces.
The Ebola virus causes viral hemorrhagic fever, which refers to a group of viruses that affect multiple organ systems in the body and are often accompanied by bleeding.
The experimental medicine is a three-mouse monoclonal antibody, meaning that mice were exposed to fragments of the Ebola virus and then the antibodies generated within the mice’s blood were harvested to create the medicine. It works by preventing the virus from entering and infecting new cells.
Developed by a San Diego Company, Mapp Biopharmaceutical, the experimental serum had never been tried before on human beings but had shown promise in small experiments with monkeys. Company documents show that four monkeys infected with Ebola survived after being given the therapy within 24 hours after infection.
In the monkeys, the experimental serum had been given within 48 hours of infection. Two of four other monkeys that started therapy within 48 hours after infection also survived. One monkey that was not treated died within five days of exposure to the virus.
Source:Nigeria recorded its first Ebola Virus disease fatality on Tuesday when one of the nurses who was one of the primary contacts of the American-Liberian, Patrick Sawyer, passed on. The doctor who treated Sawyer, who died in the country after flying into Lagos, is now ill with Ebola and six other primary contacts are currently ill with the disease in a Lagos hospital where they are quarantined.
Minister of Health, Professor Onyebuchi Chukwu and Minister of Information, Mr. Labaran Maku had disclosed on Wednesday after the Federal Executive Council meeting in Abuja that the Federal Government was awaiting the response of the request it made to the CDC on Tuesday.
Addressing the 50 African leaders at the US-African Summit in Washington, President Obama stated that it is “premature” to send an experimental medicine for the treatment of Ebola to West Africa, as he lacked enough information to approve the drug that was already being used on two American aid workers whose conditions were said to have improved by varying degrees.
“We’ve got to let the science guide us and I don’t think all the information is in on whether this drug is helpful. The Ebola virus, both currently and in the past, is controllable if you have a strong public health infrastructure in place.
“The countries affected are the first to admit that what’s happened here is the public health systems have been overwhelmed. They weren’t able to identify and then isolate cases quickly enough.
“As a consequence, it spread more rapidly than has been typical with the periodic Ebola outbreaks that occurred previously,” he remarked.
Palliative
As a palliative, President Obama announced plans by the US to spend $110 million annually, for three to five years, totall ing $330-$550 million, to help African nations develop rapid reaction peacekeeping forces.
The Ebola virus causes viral hemorrhagic fever, which refers to a group of viruses that affect multiple organ systems in the body and are often accompanied by bleeding.
The experimental medicine is a three-mouse monoclonal antibody, meaning that mice were exposed to fragments of the Ebola virus and then the antibodies generated within the mice’s blood were harvested to create the medicine. It works by preventing the virus from entering and infecting new cells.
Developed by a San Diego Company, Mapp Biopharmaceutical, the experimental serum had never been tried before on human beings but had shown promise in small experiments with monkeys. Company documents show that four monkeys infected with Ebola survived after being given the therapy within 24 hours after infection.
In the monkeys, the experimental serum had been given within 48 hours of infection. Two of four other monkeys that started therapy within 48 hours after infection also survived. One monkey that was not treated died within five days of exposure to the virus.
Source:vanguardngr.com